ALPS Advisors’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,621
| Closed | -$238K | – | 1035 |
|
|
2023
Q1 | $238K | Sell |
2,621
-125
| -5% | -$11.3K | ﹤0.01% | 965 |
|
|
2022
Q4 | $324K | Buy |
2,746
+536
| +24% | +$63.2K | ﹤0.01% | 810 |
|
|
2022
Q3 | $401K | Buy |
2,210
+523
| +31% | +$94.9K | ﹤0.01% | 658 |
|
|
2022
Q2 | $151K | Sell |
1,687
-1,233
| -42% | -$110K | ﹤0.01% | 1009 |
|
|
2022
Q1 | $453K | Sell |
2,920
-358
| -11% | -$55.5K | ﹤0.01% | 446 |
|
|
2021
Q4 | $975K | Sell |
3,278
-192
| -6% | -$57.1K | 0.01% | 363 |
|
|
2021
Q3 | $2M | Sell |
3,470
-258
| -7% | -$149K | 0.02% | 319 |
|
|
2021
Q2 | $1.69M | Sell |
3,728
-1,393
| -27% | -$633K | 0.02% | 346 |
|
|
2021
Q1 | $2.76M | Buy |
5,121
+4
| +0.1% | +$2.15K | 0.03% | 225 |
|
|
2020
Q4 | $4.52M | Buy |
+5,117
| New | +$4.52M | 0.05% | 181 |
|